DexCom Inc
General ticker "DXCM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $30.8B
DexCom Inc does not follow the US Stock Market performance with the rate: -34.7%.
Estimated limits based on current volatility of 2.4%: low 74.76$, high 78.46$
Factors to consider:
- Company included in S&P500 list
- US accounted for 72.5% of revenue in the fiscal year ended 2023-12-31
- Current price 14.0% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [93.02$, 141.95$]
- 2024-12-30 to 2025-12-30 estimated range: [95.01$, 147.15$]
Financial Metrics affecting the DXCM estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.51
- Negative: Operating cash flow per share per price, % of 1.63 <= 2.35
- Positive: 9.05 < Operating profit margin, % of 16.50
- Positive: -3.48 < Investing cash flow per share, $ of -1.31
- Positive: Interest expense per share, $ of 0.05 <= 0.14
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.14
Short-term DXCM quotes
Long-term DXCM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2,448.50MM | $2,909.80MM | $3,622.30MM |
| Operating Expenses | $2,182.70MM | $2,518.60MM | $3,024.60MM |
| Operating Income | $265.80MM | $391.20MM | $597.70MM |
| Non-Operating Income | $-9.00MM | $-0.40MM | $112.70MM |
| Interest Expense | $102.00MM | $18.60MM | $20.30MM |
| R&D Expense | $604.20MM | $484.20MM | $505.80MM |
| Income(Loss) | $256.80MM | $390.80MM | $710.40MM |
| Taxes | $39.90MM | $49.60MM | $168.90MM |
| Profit(Loss) | $216.90MM | $341.20MM | $541.50MM |
| Stockholders Equity | $2,042.10MM | $2,131.80MM | $2,068.60MM |
| Inventory | $357.30MM | $306.70MM | $559.60MM |
| Assets | $4,933.30MM | $5,391.70MM | $6,264.50MM |
| Operating Cash Flow | $442.50MM | $669.50MM | $748.50MM |
| Capital expenditure | $389.20MM | $364.80MM | $236.60MM |
| Investing Cash Flow | $-216.10MM | $-521.50MM | $-507.20MM |
| Financing Cash Flow | $10.40MM | $-552.50MM | $-318.60MM |
| Earnings Per Share* | $0.40 | $0.88 | $1.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.